Signs at AMPAC Fine Chemicals' location in the Petersburg Industrial Park have already been changed to 'Novo Nordisk' in ...

For an upcoming article, we are looking for stories about what happens to a long-term relationship when one partner decides ...

Stocks were sharply higher in early-afternoon trading Friday, reversing earlier losses, as the market reacted to tame ...

We’ve rounded up the biggest things we learned about our health this year – and what the experts had to say about them.

New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way ...

As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece.

Novo Nordisk's CargiSema Phase III trial showed significant weight loss but failed reach ambitious targets set by management.

Shares of Ozempic-maker Novo Nordisk were down more than 20% in recent trade as the Danish drugmaker headed for its worst day since the 1980s. The stock took a hit after a late-stage trial showed that ...

Shares in Novo Nordisk have fallen by more than a quarter after the Ozempic maker revealed a set of underwhelming results in ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

MILLIONAIRE ‘biohacker’ Bryan Johnson has embarked on several wacky schemes in a bid to turn back the clock. They range from infusing his son’s plasma into his blood to injecting a ...

Novo Nordisk's CagriSema Phase 3 data showed 22.7% weight loss, missing the company's own 25% target, causing a 20% drop in ...